Published in Public Health Nutr on March 02, 2009
Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med (2010) 5.18
Controlled trials in children: quantity, methodological quality and descriptive characteristics of pediatric controlled trials published 1948-2006. PLoS One (2010) 1.21
The Relationship between Risk of Bias Criteria, Research Outcomes, and Study Sponsorship in a Cohort of Preclinical Thiazolidinedione Animal Studies: A Meta-Analysis. Evid Based Preclin Med (2014) 0.94
Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: a systematic review. BMC Med Res Methodol (2013) 0.87
Funding source and research report quality in nutrition practice-related research. PLoS One (2011) 0.79
Calcium revisited: part II calcium supplements and their effects. Bonekey Rep (2014) 0.75
Reporting of sources of funding in systematic reviews in periodontology and implant dentistry. Br Dent J (2014) 0.75
Industry sponsorship and research outcome. Cochrane Database Syst Rev (2012) 7.44
Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med (2009) 5.15
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med (2008) 3.57
Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLoS Med (2013) 2.49
Financial ties and conflicts of interest between pharmaceutical and tobacco companies. JAMA (2002) 2.43
Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environ Health Perspect (2013) 2.21
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev (2010) 2.11
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Cochrane Database Syst Rev (2014) 2.10
Use of phospho-specific antibodies to determine the phosphorylation of endogenous Na+/H+ exchanger NHE3 at PKA consensus sites. Am J Physiol Renal Physiol (2005) 1.84
An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations. J Clin Invest (2007) 1.64
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ (2012) 1.58
CONSORT 2010. Lancet (2010) 1.50
The interferons and their receptors--distribution and regulation. Immunol Cell Biol (2012) 1.41
Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. Cancer Res (2004) 1.40
Medicaid drug selection committees and inadequate management of conflicts of interest. JAMA Intern Med (2013) 1.39
Linking receptor-mediated endocytosis and cell signaling: evidence for regulated intramembrane proteolysis of megalin in proximal tubule. J Biol Chem (2004) 1.33
Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. J Clin Epidemiol (2012) 1.28
A versatile pH sensitive chondroitin sulfate-PEG tissue adhesive and hydrogel. Biomaterials (2010) 1.23
Signaling crosstalk during sequential TLR4 and TLR9 activation amplifies the inflammatory response of mouse macrophages. J Immunol (2009) 1.20
Priority medicines for maternal and child health: a global survey of national essential medicines lists. PLoS One (2012) 1.19
Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials (2009) 1.19
The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev (2013) 1.12
Searching for unpublished data for Cochrane reviews: cross sectional study. BMJ (2013) 1.07
Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala. Global Health (2012) 1.05
Control at the cell center: the role of spindle poles in cytoskeletal organization and cell cycle regulation. Cell Cycle (2007) 0.98
Spindle checkpoint maintenance requires Ame1 and Okp1. Cell Cycle (2005) 0.96
Therapeutically induced changes in couple identity: the role of we-ness and interpersonal processing in relationship satisfaction. Genet Soc Gen Psychol Monogr (2006) 0.96
Chiral N-phosphonyl imine chemistry: asymmetric additions of ester enolates for the synthesis of beta-amino acids. Chem Biol Drug Des (2008) 0.96
A dynamic switch in Rb+/- mediated neuroendocrine tumorigenesis. Oncogene (2004) 0.96
Down-regulation of IRAK-4 is a component of LPS- and CpG DNA-induced tolerance in macrophages. Cell Signal (2008) 0.94
Mandatory disclosure of pharmaceutical industry-funded events for health professionals. PLoS Med (2009) 0.93
Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis. Antimicrob Agents Chemother (2005) 0.89
Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs). Bioorg Med Chem Lett (2009) 0.89
Strategies for obtaining unpublished drug trial data: a qualitative interview study. Syst Rev (2013) 0.88
Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse. Cochrane Libr (2012) 0.87
Factors associated with results and conclusions of trials of thiazolidinediones. PLoS One (2009) 0.86
Interactions between non-physician clinicians and industry: a systematic review. PLoS Med (2013) 0.83
Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds. Nicotine Tob Res (2007) 0.83
Sildenafil mediates blood-flow redistribution and neuroprotection after neonatal hypoxia-ischemia. Stroke (2014) 0.82
Regulation of the endosomal SNARE protein syntaxin 7 by colony-stimulating factor 1 in macrophages. Mol Cell Biol (2008) 0.81
Barriers and facilitators to the implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia. BMC Health Serv Res (2012) 0.81
Review of the quality of pediatric medications in developing countries. J Pharm Sci (2013) 0.81
cAMP inhibits CSF-1-stimulated tyrosine phosphorylation but augments CSF-1R-mediated macrophage differentiation and ERK activation. FEBS J (2005) 0.80
A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditions. J Am Acad Dermatol (2012) 0.79
Genetic interaction network of the Saccharomyces cerevisiae type 1 phosphatase Glc7. BMC Genomics (2008) 0.79
Could chiropractors screen for adverse drug events in the community? Survey of US chiropractors. Chiropr Osteopat (2010) 0.79
A proteomics strategy for the enrichment of receptor-associated complexes. Proteomics (2005) 0.78
A clearer view of evidence in treating macular degeneration: off-label policies and independent research. Cochrane Database Syst Rev (2014) 0.78
Cation exchange surface-mediated denaturation of an aglycosylated immunoglobulin (IgG1). J Chromatogr A (2012) 0.77
A potential role for the Src-like adapter protein SLAP-2 in signaling by the colony stimulating factor-1 receptor. FEBS J (2006) 0.77
Regulatory agencies hold the key to improving Cochrane reviews of drugs. Cochrane Database Syst Rev (2015) 0.77
Conflicts of Interest and the Presence of Methodologists on Guideline Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major Depressive Disorder. Psychother Psychosom (2017) 0.76
Dilute betadine lavage reduces implant-related bacterial burden in a rabbit knee prosthetic infection model. Am J Orthop (Belle Mead NJ) (2015) 0.76
The formation of ordered nanoclusters controls cadherin anchoring to actin and cell-cell contact fluidity. J Cell Biol (2015) 0.76
Antidepressants, sex steroids and pituitary-adrenal response in sheep. Psychopharmacology (Berl) (2004) 0.76
Cation exchange chromatography provides effective retrovirus clearance for antibody purification processes. Biotechnol Bioeng (2011) 0.76
Instruments for assessing risk of bias and other methodological criteria: Krauth et al. Respond. Environ Health Perspect (2014) 0.75
Does Blast Medium Affect Heterotopic Ossification in a Blast-amputation Model? Clin Orthop Relat Res (2015) 0.75
Ischemic postconditioning fails to protect against neonatal cerebral stroke. PLoS One (2012) 0.75
Determination of polycyclic aromatic hydrocarbons in dry tea. J Environ Sci Health B (2015) 0.75
Clarification of study and citation. Arch Intern Med (2007) 0.75
Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: interim results of a single-arm, open-label study. J Dermatolog Treat (2011) 0.75
Systematic reviews: perhaps "the answer to policy makers' prayers"? Environ Health Perspect (2014) 0.75
Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison. Asian Pac J Allergy Immunol (2016) 0.75
Chiral building blocks: enantioselective syntheses of benzyloxymethyl phenyl propionic acids. Molecules (2004) 0.75
The Cochrane Library Oversight Committee. Cochrane Database Syst Rev (2011) 0.75
"Zone of vulnerability" for radial nerve injury: anatomic study. J Surg Orthop Adv (2014) 0.75
Policies affecting the supply and access of opioid analgesics: a scoping review protocol. JBI Evid Synth (2020) 0.75
Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme. Int J Pharm Pract (2010) 0.75
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev (2016) 0.75
Synthesis of chiral building blocks for use in drug discovery. Molecules (2004) 0.75
Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study. J Dermatolog Treat (2012) 0.75